(Q44936272)

English

Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies (English)
Annekathryn Goodman
Gynecologic Oncology Research Program at Dana Farber/Partners CancerCare

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit